Sofwave Receives FDA Clearance for Treating Upper Arm Skin Laxity
The FDA clearance of Sofwave to treat upper arm skin laxity comes as the American Society of Plastic Surgeons reports brachioplasty procedures grew 25% between 2019-2022.
The FDA clearance of Sofwave to treat upper arm skin laxity comes as the American Society of Plastic Surgeons reports brachioplasty procedures grew 25% between 2019-2022.
New sizes for the Mia and Preserve systems expand the company’s minimally invasive breast offerings. The company also presented new clinical data on breast tissue preservation to more than 1,000 plastic surgeons.